Home > Healthcare > Analytical Instruments > Elemental Analysis > Hyperspectral Imaging Systems Market
Based on product, the hyperspectral imaging systems market is segmented into camera, accessories. The camera segment held the largest revenue size over USD 9 billion in 2022 and is estimated to witness significant growth more than USD 29 billion by 2032. Factors such as recent advancements in the development of sensors have contributed to the growth of the camera segment. The development of highly sensitive and high-resolution sensors, such as charge-coupled devices (CCDs) and complementary metal-oxide-semiconductor (CMOS) sensors, has greatly improved the performance of hyperspectral imaging systems. Moreover, modern hyperspectral cameras can cover a wider spectral range, including the visible, near-infrared (NIR), and shortwave infrared (SWIR) regions of the electromagnetic spectrum. Therefore, with ongoing technological advancements and cost reductions, cameras will continue to play a pivotal role in expanding the capabilities and applications of hyperspectral imaging.
Based on technology, the hyperspectral imaging systems market is bifurcated into push broom, snapshot, and others. The snapshot segment is anticipated to witness highest CAGR at 12.1% during the forecast period. The growth of snapshot technology in hyperspectral imaging systems is driven by several factors that contribute to its increased adoption and expanded applications such as patient’s snapshot which delivers aggregated view of patient’s entire clinical data at once. Snapshot hyperspectral imaging systems provide real-time imaging capabilities, enabling immediate data acquisition and analysis.
Hyperspectral imaging systems market is bifurcated based on the application including military, remote sensing, medical diagnostics, machine vision & optical sorting, and others. The medical diagnostics segment is anticipated to witness highest CAGR at 12% during the forecast period. Diagnostic information about tissue anatomy, content, and physiology is provided via hyperspectral imaging. The identification of the spread of a disease, the scattering, fluorescence, and absorption of the tissue change through this type of imaging have a wide range of applications in tissue pathology diagnostics.
Hence, hyperspectral imaging can be widely used in gastrointestinal procedures, ophthalmology diagnostics, fluorescence microscopy, advanced wound care management, cell biology, and vascular systems. Due to ongoing innovation and technological breakthroughs, high clarity and accuracy in this technology are expected to generate growth prospects in medical diagnostics industry during the projected years.
U.S. hyperspectral imaging systems market accounted for more than USD 5 billion in 2022 and will grow momentously more than USD 14 billion by 2032. This is owing to the region's strong healthcare infrastructure, high healthcare spending, adoption of cutting-edge technologies, and the presence of numerous industry participants. The region's scientific activities have also increased due to better funding.
In addition, to having significant research funding through government organisations such as the National Institutes of Health (NIH), the country spends majority of its funds on healthcare. Market expansion is accelerating as a result of the focus on healthcare and efforts related to it, such as the Patient Protection and Affordable Care Act.